The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Communications and UpdatesFull Access

Right Versus Left Hippocampal Activity as a Biomarker in Schizophrenia

To the Editor: In their article published in the May 2014 issue of the Journal, Jason R. Tregellas, Ph.D., et al. (1), state that their hypothesis “that patients would show greater intrinsic hippocampal activity than healthy subjects” was supported. However, their original hypothesis said nothing about the right or left hippocampus.

The impressive Figure 2, showing the difference between schizophrenia patients and control subjects, is only the data from the right hippocampus. The text states that there were no group differences in the left hippocampus, and since the N was relatively small, I would expect that a test of their original hypothesis, that hippocampal activity would be higher in schizophrenia patients, was probably not supported (i.e., a test comparing schizophrenia patients and control subjects on total hippocampal activity would not have been statistically significant).

Therefore, the comparison that they found to be significant, involving only the right hippocampus, was a post hoc comparison and not a test of their original hypothesis.

From the Psychopharmacology Research Association of Princeton, Princeton, N.J.

The author reports no financial relationships with commercial interests.

1 Tregellas JR, Smucny J, Harris JG, Olincy A, Maharajh K, Kronberg E, Eichman LC, Lyons E, Freedman R: Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry 2014; 171:549–556LinkGoogle Scholar